T1	CHEM 62 68	DAY101
T2	PROC 81 103	quimioterapia estándar
T3	LIVB 107 128	pacientes pediátricos
T4	Age 117 128	pediátricos
T5	DISO 133 153	glioma de bajo grado
#1	AnnotatorNotes T5	C1997217; Low grade glioma; Neoplastic Process
T6	PROC 167 205	tratamiento sistémico de primera línea
T7	PROC 245 308	Ensayo en fase III, aleatorizado, internacional y multicéntrico
T8	CHEM 312 318	DAY101
T9	PROC 322 333	monoterapia
#2	AnnotatorNotes T9	C4763675; Single Agent Therapy; Therapeutic or Preventive Procedure
T10	PROC 346 368	quimioterapia estándar
T11	LIVB 372 381	pacientes
#3	AnnotatorNotes T11	C0030705; Patients; Patient or Disabled Group
T12	DISO 386 417	glioma pediátrico de bajo grado
T15	PROC 478 516	tratamiento sistémico de primera línea
T16	DISO 538 552	Tumor cerebral
#5	AnnotatorNotes T16	C0006118; Brain Neoplasms; Neoplastic Process
T17	LIVB 556 561	niños
#6	AnnotatorNotes T17	C0008059; Child; Age Group | C0870221; Boys; Age Group
T18	Age 556 561	niños
T19	LIVB 564 579	adultos jóvenes
T20	Age 564 579	adultos jóvenes
T21	PROC 594 605	tratamiento
#7	AnnotatorNotes T21	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T22	DISO 646 677	Glioma pediátrico de bajo grado
T24	PROC 737 775	tratamiento sistémico de primera línea
T25	Age 809 827	inferior a 25 años
T26	DISO 830 850	glioma de bajo grado
#9	AnnotatorNotes T26	C1997217; Low grade glioma; Neoplastic Process
T28	PROC 891 918	Diagnóstico histopatológico
T29	DISO 922 928	glioma
#11	AnnotatorNotes T29	C0017638; Glioma; Neoplastic Process
T30	DISO 931 949	tumor glioneuronal
T31	DISO 966 980	lesión medible
T32	PROC 1054 1092	tratamiento sistémico de primera línea
T35	DISO 1196 1201	tumor
#12	AnnotatorNotes T35	C0027651; Neoplasms; Neoplastic Process | C0038999; Swelling; Finding
T36	DISO 1207 1217	Schwannoma
#13	AnnotatorNotes T36	C0027809; Neurilemmoma; Neoplastic Process
T37	DISO 1222 1268	Astrocitoma subependimario de células gigantes
#14	AnnotatorNotes T37	C0205768; Subependymal Giant Cell Astrocytoma; Neoplastic Process
T38	DISO 1270 1289	Esclerosis Tuberosa
#15	AnnotatorNotes T38	C0041341; Tuberous Sclerosis; Neoplastic Process
T39	DISO 1295 1327	Glioma pontino intrínseco difuso
#16	AnnotatorNotes T39	C2986658; Diffuse Intrinsic Pontine Glioma; Neoplastic Process
T40	PROC 1343 1366	diagnóstico histológico
T42	DISO 1462 1467	tumor
#17	AnnotatorNotes T42	C0027651; Neoplasms; Neoplastic Process | C0038999; Swelling; Finding
T43	PROC 1471 1482	Diagnóstico
#18	AnnotatorNotes T43	C0011900; Diagnosis; Diagnostic Procedure
T44	Spec_cue 1494 1502	presunto
T45	DISO 1506 1537	neurofibromatosis de tipo 1 o 2
T46	Speculated 1506 1537	neurofibromatosis de tipo 1 o 2
T47	DISO 1539 1543	NF-1
#19	AnnotatorNotes T47	C0027831; Neurofibromatosis 1; Neoplastic Process
T48	Speculated 1539 1543	NF-1
T49	DISO 1544 1548	NF-2
#20	AnnotatorNotes T49	C0027832; Neurofibromatosis 2; Neoplastic Process
T50	Speculated 1544 1548	NF-2
T51	PROC 1553 1593	Tratamiento antineoplásico no quirúrgico
T52	Negated 1583 1593	quirúrgico
T54	PROC 1644 1657	quimioterapia
#21	AnnotatorNotes T54	C0013216; Pharmacotherapy; Therapeutic or Preventive Procedure | C0392920; Chemotherapy Regimen; Therapeutic or Preventive Procedure | C3665472; Chemotherapy; Therapeutic or Preventive Procedure
T55	PROC 1659 1677	terapias dirigidas
#22	AnnotatorNotes T55	C0278348; Immunotherapy for cancer; Therapeutic or Preventive Procedure
T56	Route 1682 1690	vía oral
T57	Route 1693 1696	i.v
T58	PROC 1712 1724	radioterapia
#23	AnnotatorNotes T58	C0041626; Ultraviolet Therapy; Therapeutic or Preventive Procedure | C1522449; Therapeutic radiology procedure; Therapeutic or Preventive Procedure
T59	Date 12 16	2022
T23	DISO 695 723	alteración de RAF activadora
T13	DISO 436 464	alteración de RAF activadora
T14	DISO 859 887	alteración de RAF activadora
T27	PROC 1007 1021	criterios RANO
T33	DISO 1419 1455	alteraciones moleculares activadoras
T41	Neg_cue 1580 1582	no
T34	Route 179 188	sistémico
T53	Route 490 499	sistémico
T60	Route 749 758	sistémico
T61	Route 1066 1075	sistémico
